Seres Therapeutics (MCRB) Stock: Buy, Sell, or Hold?
MCRB - Seres Therapeutics, Inc.
$2.02
-0.28 (-12.17%)
▼
5d:
-20.16%
30d:
-46.7%
90d:
-59.32%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 04, 2026
12d
Get Alerted When MCRB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: MCRB is down 20.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: MCRB is down 20.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: MCRB is currently trading at $2.02, which is considered oversold relative to its 30-day fair value range of $2.44 to $3.93.
Technical Outlook: Technically, MCRB is in a strong downtrend. The price is currently testing key support at $2.26. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 12.2% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Implied Volatility is high (74th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $17.00 (+639.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MCRB is in a strong downtrend. The price is currently testing key support at $2.26. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 12.2% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Implied Volatility is high (74th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $17.00 (+639.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.44 -
$3.93
Company Quality Score
53/100
(HOLD)
Options IV Signal
74th percentile
(EVENT RISK)
Volume Confirmation
HIGH
Confidence Score
61.3%
Protect Your Profits
Holding MCRB? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Options expensive (IV 74th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-12.2%)
- BULLISH: Trading 639.1% below Wall St target ($17.00)
- WARNING: Composite score 53/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.44 -
$3.93
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.62
(30.5%)
Support & Resistance Levels
Support Level
$2.26
Resistance Level
$2.78
Current Trend
Strong Downtrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.47
Wall Street Target
$17.00
(+639.1%)
Revenue Growth (YoY)
-93.4%
Earnings Growth (YoY)
-91.9%
Share & Embed Analysis
Last updated: October 22, 2026 10:07 AM ET
Data refreshes hourly during market hours. Next update: 11:07 AM
Data refreshes hourly during market hours. Next update: 11:07 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MCRB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
24 analysts |
$258 | 58 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 59 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$36 | 58 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
15 analysts |
$52 | 62 BUY |
|
SNDX
Syndax Pharmaceuticals I… |
STRONG BUY
12 analysts |
$37 | 63 BUY |
Advanced MCRB Option Strategies
Professional options setups generated by AI based on today's MCRB price and gamma walls.
